A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/215 (2006.01) A61K 31/19 (2006.01) A61P 25/28 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2207437
The invention concerns the use of incense (Olibanum), incense extracts, substances contained in incense, their physiologically acceptable salts, their derivatives, and physiologically acceptable salts of the derivatives, pure boswellic acid, a physiologically acceptable salt, a derivative, or a salt of the derivative, in the prevention or treatment of Alzheimer's disease.
L'invention concerne l'utilisation, pour la prévention ou le traitement de la maladie d'Alzheimer, d'encens (Olibanum), d'extraits d'encens, de substances contenues dans l'encens, de leurs sels phyiologiquement acceptables, de leurs dérivés et de leurs sels physiologiquement acceptables, d'acide boswellique pur, d'un sel physiologiquement acceptable, d'un dérivé, ou d'un sel du dérivé.
Ayurmedica Arzneimittelforschung Und-Grosshandel Gmbh & Co. Betr
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Etzel Rainer
LandOfFree
Use of incense in the treatment of alzheimer's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of incense in the treatment of alzheimer's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of incense in the treatment of alzheimer's disease will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1565039